GV 2017 GP, L.L.C.

CIK 1733338 · last filed 2026-01-30

GV 2017 GP, L.L.C. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for LIFE, was dated Jan 30, 2026. Across all open-market trades the lifetime net is −$385.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.21B across reported positions. The firm reports its address in Mountain View, CA. 14 SEC filings were submitted jointly with GV 2017 GP, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.21B

Companies

3

Total Filings

4

Lifetime Open-Market Net

-$385.67M

Filer Profile

Reported Address

1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW, CA 94043

Phone

(650) 335-5278

State of Incorporation

Related Filers

GV 2017 GP, L.P. — 14 joint filings, latest 2026-01-30

Alphabet Inc. — 10 joint filings, latest 2026-01-30

GV 2019 GP, L.L.C. — 6 joint filings, latest 2026-01-30

GV 2019 GP, L.P. — 6 joint filings, latest 2026-01-30

GV 2019, L.P. — 6 joint filings, latest 2026-01-30

GV 2021 GP, L.L.C. — 2 joint filings, latest 2026-01-30

GV 2021 GP, L.P. — 2 joint filings, latest 2026-01-30

GV 2021, L.P. — 2 joint filings, latest 2026-01-30

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LIFE	10%+ Owner	3,287,925	$34.34	$112.92M	-$350.61M	1	2026-01-30
GOOGL	10%+ Owner	3,198,249	$344.16	$1.10B	-$35.06M	2	2026-01-30
Verve Therapeutics, Inc. (VERV) Delisted	10%+ Owner	6,320,905	$11.13	$70.35M	$0	1	2021-06-22

Recent Filings

4 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-01-30	LIFE	Mixed	+37,701,560	-$350.61M	EDGAR
2026-01-30	GOOGL	Mixed	+3,770,156	-$35.06M	EDGAR
2025-07-28	GOOGL	U	−12,168,489	$0	EDGAR
2021-06-22	Verve Therapeutics, Inc. (VERV) Delisted	Conv (C)	+18,962,715	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.